NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions

Go back to NKGen Biotech to Present at the 2026 BIOCHINA Global Forum on Troculeucel’s Potential in Alzheimer’s Disease and Other Neurodegenerative Conditions
(NASDAQ: NKGN) Delayed: 0.19 --0 (-0%)
Previous Close $0.19    52 Week High
Open $0.19    52 Week Low
Day High $0.19    P/E N/A 
Day Low $0.19    EPS
Volume 24,517